Related Experiment Videos
[ACE inhibitors and the kidney]
1Klinischen Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Wien.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1996
Summary
Renal hypertension, often caused by kidney diseases, accelerates chronic kidney failure. Effective blood pressure management, particularly with ACE inhibitors, protects kidneys by lowering pressure and reducing protein in urine.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Hypertension Research
Context:
- Renal diseases like glomerulonephritis, diabetic nephropathy, and interstitial nephritis are primary causes of renal hypertension.
- Elevated blood pressure is a critical driver for the progression of chronic kidney disease.
- Systemic diseases with renal involvement also contribute significantly to renal hypertension.
Purpose:
- To elucidate the role of various renal pathologies in causing renal hypertension.
- To highlight the detrimental impact of high blood pressure on chronic renal failure progression.
- To underscore the renoprotective benefits of antihypertensive therapies, specifically ACE inhibitors.
Summary:
- Clinical and experimental data confirm that angiotensin-converting enzyme (ACE) inhibitors offer renoprotection.
- ACE inhibitors achieve this by reducing systemic blood pressure and glomerular capillary pressure.
- Further renoprotective mechanisms include reduction of proteinuria and antiproliferative effects.
Impact:
- Effective antihypertensive therapy, especially with ACE inhibitors, can significantly slow the progression of chronic kidney disease.
- Understanding these mechanisms aids in developing targeted treatments for hypertensive nephropathies.
- This research emphasizes the critical link between blood pressure control and kidney health preservation.